ATE126211T1 - 2-decarboxyl-2-alkoxyalkyl-prostaglandine als augenbinnendrucksenkende mittel. - Google Patents

2-decarboxyl-2-alkoxyalkyl-prostaglandine als augenbinnendrucksenkende mittel.

Info

Publication number: ATE126211T1
Authority: AT; Austria
Prior art keywords: decarboxyl; alkoxyalkyl; carbon atoms; configuration; prostaglandins
Prior art date: 1990-12-06

Application number

AT92902998T

Other languages

English (en)

Inventor

Ming Fai Chan

David Frederick Woodward

Original Assignee

Allergan Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-06

Filing date

1991-12-04

Publication date

1995-08-15

1991-12-04 Application filed by Allergan Inc filed Critical Allergan Inc

1995-08-15 Application granted granted Critical

1995-08-15 Publication of ATE126211T1 publication Critical patent/ATE126211T1/de

Links

229940094443 oxytocics prostaglandins Drugs 0.000 title abstract 3
150000003180 prostaglandins Chemical class 0.000 title 1
125000004432 carbon atom Chemical group C* 0.000 abstract 4
125000001931 aliphatic group Chemical group 0.000 abstract 3
150000001875 compounds Chemical class 0.000 abstract 2
208000010412 Glaucoma Diseases 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
125000002015 acyclic group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
231100000252 nontoxic Toxicity 0.000 abstract 1
230000003000 nontoxic effect Effects 0.000 abstract 1
229940054534 ophthalmic solution Drugs 0.000 abstract 1
239000002997 ophthalmic solution Substances 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
229940127557 pharmaceutical product Drugs 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Ophthalmology & Optometry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT92902998T 1990-12-06 1991-12-04 2-decarboxyl-2-alkoxyalkyl-prostaglandine als augenbinnendrucksenkende mittel. ATE126211T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/623,234 US5139491A (en)	1990-12-06	1990-12-06	2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives

Publications (1)

Publication Number	Publication Date
ATE126211T1 true ATE126211T1 (de)	1995-08-15

Family

ID=24497288

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92902998T ATE126211T1 (de)	1990-12-06	1991-12-04	2-decarboxyl-2-alkoxyalkyl-prostaglandine als augenbinnendrucksenkende mittel.

Country Status (12)

Country	Link
US (1)	US5139491A (de)
EP (1)	EP0562016B1 (de)
JP (1)	JP3186766B2 (de)
AT (1)	ATE126211T1 (de)
AU (1)	AU645647B2 (de)
BR (1)	BR9107155A (de)
CA (1)	CA2096945A1 (de)
DE (1)	DE69112080T2 (de)
ES (1)	ES2075679T3 (de)
HU (1)	HUT67535A (de)
IE (1)	IE914231A1 (de)
WO (1)	WO1992010473A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5238961A (en) *	1990-06-14	1993-08-24	Allergan, Inc.	Pgf 1-alcohols and their use as ocular hypotensives
US5288754A (en) *	1992-02-04	1994-02-22	Allergan, Inc.	Polar C-1 esters of prostaglandins
US6124353A (en) *	1992-11-12	2000-09-26	Allergan Sales, Inc.	Method of treating ocular hypertension with 8-epi prostaglandins
US5476872A (en) *	1993-10-18	1995-12-19	Allergan, Inc.	1,11-diesters of prostaglandin-F2α having a polar ester group at C-1
US20090082455A1 (en) *	2005-03-15	2009-03-26	Ono Pharmaceutical Co. Lted	Therapeutic agent for ophthalmic disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3069322A (en) *	1958-05-28	1962-12-18	Bergstrom Sune	Pge and pgf
FR2278322A1 (fr) *	1972-12-05	1976-02-13	Ono Pharmaceutical Co	Compositions contenant des prostaglandines
NL7605381A (nl) *	1975-05-26	1976-11-30	Schering Ag	Werkwijze voor het bereiden van prostaanderi- vaten en werkwijze voor het bereiden van een geneesmiddel met prostaglandinewerking.
GB2048254B (en) *	1979-04-02	1983-05-25	Upjohn Co	19,20 -didehydro-19-hydroxy and 19-oxo-prostaglandin derivatives
GB8528032D0 (en) *	1985-11-13	1985-12-18	Ici Plc	Ocular treatment
US4824857A (en) *	1986-05-16	1989-04-25	Yasumasa Goh	Use of prostaglandin D2 -active substances
US4822820A (en) *	1986-11-24	1989-04-18	Alcon Laboratories, Inc.	Use of tri-methyl PG-F2 a and derivatives in glaucoma therapy
ES2052735T3 (es) *	1987-09-18	1994-07-16	R Tech Ueno Ltd	Un metodo para producir un agente hipotensor ocular.
US4994274A (en) *	1989-07-27	1991-02-19	Allergan, Inc.	Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5011856A (en) *	1990-03-12	1991-04-30	Allergan, Inc.	Use of prostaglandin F3 α as an ocular hypotensive agent
US5238961A (en) *	1990-06-14	1993-08-24	Allergan, Inc.	Pgf 1-alcohols and their use as ocular hypotensives

1990
- 1990-12-06 US US07/623,234 patent/US5139491A/en not_active Expired - Fee Related
1991
- 1991-12-04 EP EP92902998A patent/EP0562016B1/de not_active Expired - Lifetime
- 1991-12-04 HU HU9301348A patent/HUT67535A/hu unknown
- 1991-12-04 ES ES92902998T patent/ES2075679T3/es not_active Expired - Lifetime
- 1991-12-04 AT AT92902998T patent/ATE126211T1/de not_active IP Right Cessation
- 1991-12-04 AU AU91611/91A patent/AU645647B2/en not_active Ceased
- 1991-12-04 DE DE69112080T patent/DE69112080T2/de not_active Expired - Fee Related
- 1991-12-04 CA CA002096945A patent/CA2096945A1/en not_active Abandoned
- 1991-12-04 WO PCT/US1991/009071 patent/WO1992010473A2/en not_active Ceased
- 1991-12-04 JP JP50315692A patent/JP3186766B2/ja not_active Expired - Fee Related
- 1991-12-04 BR BR919107155A patent/BR9107155A/pt not_active Application Discontinuation
- 1991-12-05 IE IE423191A patent/IE914231A1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
HU9301348D0 (en)	1993-09-28
EP0562016B1 (de)	1995-08-09
WO1992010473A3 (en)	1992-08-20
HUT67535A (en)	1995-04-28
US5139491A (en)	1992-08-18
BR9107155A (pt)	1993-11-16
ES2075679T3 (es)	1995-10-01
EP0562016A1 (de)	1993-09-29
IE914231A1 (en)	1992-06-17
AU9161191A (en)	1992-07-08
DE69112080D1 (de)	1995-09-14
JP3186766B2 (ja)	2001-07-11
JPH06503346A (ja)	1994-04-14
WO1992010473A2 (en)	1992-06-25
AU645647B2 (en)	1994-01-20
DE69112080T2 (de)	1996-01-11
CA2096945A1 (en)	1992-06-07

Similar Documents

Publication	Publication Date	Title
DE3271269D1 (en)	1986-06-26	Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
ZA911403B (en)	1991-11-27	Derivatives having a naphthalene structure,process for preparing these and pharmaceutical compositions containing them
WO1993014743A3 (en)	1994-01-06	Polar c-1 esters of prostaglandins
DE3272792D1 (en)	1986-10-02	Process for the preparation of 2-penem compounds
DE69121408D1 (de)	1996-09-19	Pgf 1-alkohole und deren verwendung als augendrucksenkende mittel
DK0474712T3 (da)	1993-11-29	Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat
ES8505650A1 (es)	1985-06-01	Un metodo de producir una emulsion grasa que contiene ester alquilico de prostaglandina e1
AU5791190A (en)	1991-01-03	New peptide derivatives, process for preparing them and pharmaceutical compositions containing them
GB1173872A (en)	1969-12-10	N-2-Ethylhexyl-N'-Aryl Ureas and Preparations containing them
ATE126211T1 (de)	1995-08-15	2-decarboxyl-2-alkoxyalkyl-prostaglandine als augenbinnendrucksenkende mittel.
DE3170937D1 (en)	1985-07-18	2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them
MX9204457A (es)	1993-05-01	Compuestos de 6-oxo-azepinoidol, asi como procedimientos y productos intermedios para su preparacion, y medicamentos que contienen estos compuestos.
ATE74924T1 (de)	1992-05-15	N-(vinblastinoyl-23)-derivate von 1aminomethylposphons\|ure, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
ES8200648A2 (es)	1981-12-01	Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
ATE94532T1 (de)	1993-10-15	Neue leukotrien-b4-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE30712T1 (de)	1987-11-15	4-hydroxy-alpha-aethyl-benzhydrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
GB952547A (en)	1964-03-18	Improvements in or relating to novel substituted phenylalkylamines
ES467791A1 (es)	1978-10-16	Procedimiento para la obtencion de nuevos derivados del 1- fenil-2-amino-1,3-propandiol-n-alcohilo.
KR910011846A (ko)	1991-08-07	디옥사닐피리딘
GB1412663A (en)	1975-11-05	2- 4-biphenylyl- tetrahydrofurans and pharmaceutical compositions containing them
ATE11141T1 (de)	1985-01-15	Neue cephalosporine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE63305T1 (de)	1991-05-15	Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.

Legal Events

Date	Code	Title	Description
1996-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties